Bayer, the largest German drugmaker, is reportedly in the beginning stages of considering a bid for the Pfizer Animal Health division, which could sell for $14 billion to $18 billion in a sale.

According to Bloomberg, the bid for Pfizer’s Animal Health unit would be Bayer’s second attempt in three years to strengthen its production of veterinary products.

Read more from Bloomberg news.